Trailing-twelve-month (TTM) net income is $5.25 Billion with a year-over-year change of +8.50%. Net income represents the company's bottom line profit after all expenses, taxes, and interest.
Reported quarterly net income; no daily interpolation. Q2 FY2026 (2026-06-30): $1.09B.
Net Income growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:03.000Z. Historical observations retain their original dates. Historical series through 2026-09-09.
$5.25B
$5.25 Billion
+8.50%
vs. $4.84B a year ago (TTM)
+11.85%
5 Year compound annual growth rate
1 Year
+8.50%
3 Year
+52.16%
5 Year
+11.85%
10 Year
+7.23%
15 Year
+6.49%
20 Year
+6.98%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Net Income | YoY Change | % Change |
|---|---|---|---|
| 2025 | $4.97B | +$458.00M | +10.16% |
| 2024 | $4.51B | +$214.00M | +4.98% |
| 2023 | $4.30B | +$1.75B | +68.47% |
| 2022 | $2.55B | ($1.36B) | (34.75%) |
| 2021 | $3.91B | +$2.53B | +183.81% |
| 2020 |
TTM Growth
+8.50%
3-Year CAGR
+52.16%
5-Year CAGR
+11.85%
Unrounded diluted TTM EPS / FMP quote price × 100 Quote observation: 2026-09-09T20:00:03.000Z. Historical observations retain their original dates. Historical series through 2026-09-09.
| $1.38B |
| ($2.37B) |
| (63.26%) |
| 2019 | $3.75B | +$1.08B | +40.59% |
| 2018 | $2.67B | ($393.00M) | (12.85%) |
| 2017 | $3.06B | +$393.00M | +14.74% |
| 2016 | $2.67B | ($195.00M) | (6.82%) |
